INDEX, the journal of Pharmacy Technology VOLUME TWENTY — JANUARY THROUGH DECEMBER 2004 January/February Pages 1-68 July/August Pages 213-264 March/April Pages 69-148 September/October Pages 265-320 May/June Pages 149-212 November/December Pages 321-378 Antiarrhythmics, safety in breast-feeding (A), Biotin, reduces blood glucose in combination A-C 88 with chromium picolinate (TT), 289 Antiasthmatics, safety in breast-feeding (A), Blood Pressure Elevation with Rofecoxib in Abstinence, message preferred by parents 19 Older Adults (A), 80 (WN), 129 Antibacterials, increase in resistant bacteria Book reviews, see New Publications Accreditation Council for Pharmacy Educa- (WN), 345; kill bacteria but not viruses Books received, 60, 142, 205, 257, 313 tion (ACPE), name change (PF), 53 (WN), 193 Boothby, Lisa A (author) When Prescription ACE inhibitors, safety in breast-feeding (A), Anticoagulants, safety in breast-feeding (A), Drugs Go Over-the-Counter: Where Are the 86 87 Boundaries? (A), 215 Acetazolamide, oral suspension (CF), 357 Antidiabetics, safety in breast-feeding (A), 20 Borcherding, Shawn M (author) book review, Acute care, pharmacist initiative reduces wait- Antihistamines, safety in breast-feeding (A), 364 ing time (PF), 351 21; usage does not correlate with allergic Botulinum toxin, effective for hyperhidrosis Acute coronary syndrome, managed with disease (WN), 295 (TT), 121 enoxaparin (TT), 288; treated with statins Antihypertensives, safety in breast-feeding Brand-name drugs, preferred by consumers (TT), 186 (A), 89 (PF), 245 Adalimumab, effective in rheumatoid arthri- Antiinfectives, safety in breast-feeding (A), Breast cancer, exemestane reduces recurrence tis (TT), 293 167 (WN), 194; improved survival with doce- Adherence, improved by hospital involve- Appearance of Retinal Hemorrhages in Pa- taxel (TT), 45; relationship with smoking ment (TT), 41; improved by smart packag- tients on Daily-Dose Anti-Tubercular (TT), 123 ing (TT), 135 Therapy (A), 276 Breast-feeding, high incidence in USA (WN), African Americans, effects of B-blockers in Argatroban, tolerated in ESRD hemodialysis 50; safety with medications (A), 17; (A), 85; (A), 165; safety of fluoxetine (WN), 49 chronic heart failure (A), 336 (TT), 46 Butorphanol, kinetics of intranasal absorption Al-Arifi, Mohammed Nasir (author) Preva- Aspirin, associated with pancreatic cancer (TT), 184 lence of Smoking and Attitude Toward (TT), 123; negates gastrointestinal benefits Calcium-channel blockers, safety in breast- Smoking Cessation Among Community of COX-2 inhibitors (WN), 296; resistance feeding (A), 91 Pharmacists, Saudi Arabia (A), 329 test available (WN), 297; underused in Calendar of Events, 57, 138, 203, 253, 309, 356 Alam, Mohammed Adnan (coauthor) see those with heart disease (TT), 235 California, technician impact on sterile com- Iqbal, Mohammad Masud (A), 155 Asthma, difficulties linked with empty me- pounding (FS), 248 Albrecht, Linda S (author) book review, 256 tered dose inhaler canisters (WN), 47; non- Candesartan, effective in chronic heart failure Alosetron, available at lower dosage (WN), compliance during pregnancy (WN), 126 (TT), 185 192 Atopic dermatitis, improvements with clocor- Capecitabine, associated diarrhea (A), 226 Alzheimer’s disease, brief review (MP), 212; tolone and tacrolimus combination (TT), 43 Captopril, oral solution (CF), 254 predicted by MRI (WN), 49 Atorvastatin, halts arterial plaque progression Carter, D Brent (coauthor), see Veverka, Angie, American Association of Clinical Endocri- (TT), 42; halts progression of heart disease 336 nologists (AACE), Web site for patient edu- (TT), 185 Carvedilol, improves heart failure outcomes cation (WN), 48 Atrial fibrillation, dangerous for women (TT), 42 American Pharmacists Association (APhA), (WN), 191 Cefdinir, adherence high in children (WN), launches prep course for pharmacy techni- Automation, reduces hospital drug distribu- 301; recommended in sinus and allergy cians (PF), 198 tion errors (WN), 346 guidelines (WN), 193 AmerisourceBergen, automated storage and Azathioprine, efficacy in lupus nephritis (TT), Children, at risk for undetected adverse reac- retrieval systems (WN), 129 188 tions (WN), 346 ; not treated for postopera- Amiodarone, effectiveness of a monitoring Bar coding, reduces medication errors (PF), 53 tive pain (WN), 348 clinic (A), 5 Benazepril, generic approved (WN), 127 Cholesterol, role of pharmacist (PF), 135 Amlodipine, oral suspension (CF), 357 Benign prostatic hyperplasia, high incidence Chromium picolinate, reduces blood glucose Analgesics, misuse of OTC pain relievers of sexual dysfunction (WN), 241 in combination with biotin (TT), 289 (WN), 300; safety in breast-feeding (A), 23 Benzodiazepines, safety in breast-feeding (A), Cilostazol, reduces coronary stent blockage Anderson, Howard C Jr. (coauthor) see Peter- 171 (TT), 43 son, Charles D (A), 28 B-Blockers, beneficial for peanut allergy in Citalopram, association with hypertension Aneja, Alka (coauthor) see Iqbal, Moham- those with heart disease (TT), 234; decrease (A), 14 mad Masud (A), 155 risk for fractures (TT), 343; safety in breast- Clonazepam, oral suspension (CF), 204 Anesthetics, safety in breast-feeding (A), 26 feeding (A), 90; use in African Americans Clonidine, reduces death associated with Anthrax, medical countermeasures (FL), 132 with chronic heart failure (A), 336 surgery (TT), 289 WWW.JPHARMTECHNOL.COM Novemser/Decemser 2004 @ Voiume 20 @ J PHARMTECHNOL 373 Clozapine, interaction with phenytoin (A), Eggs, not associated with elevated LDL-C Clinic in Improving Adherence to Amio- 280; managing adverse effects (A), 155 (WN), 297 darone Monitoring Guidelines (A), 5 Colorectal cancer, risk reduced by mesalazine Electronic messaging, guidelines available Gromelski, Joseph S (coauthor) see Nice, (TT), 46 (PF), 307 FrankJ (A), 17, 85, 165 A Complex Interaction Between Clozapine e-Mail, physicians use (WN), 296 Gupta, Nitin (coauthor) see Malhotra, Pankaj and Phenytoin (A), 280 Enalapril, oral suspension (CF), 254 (A), 11 Compliance tools, smart medication bottles End-of-life, treatment conflicts with advance Hand hygiene, importance underestimated (WN), 191; to increase medication adher- directives (TT), 292 (WN), 299 ence (PF), 135 Eng, Marty L (author) Blood Pressure Eleva- Hastings, Jan K (author) book review, 59 Compounding Formulations, amiodarone tion with Rofecoxib in Older Adults (A), 80 HDL-C, as a predictor of heart disease (WN), oral suspension, 310; atenolol oral suspen- Enoxaparin, effective in acute coronary syn- 47 sion, 310; captopril oral solution, 254; clon- dromes (TT), 288 Health Information Web Sites by Therapeu- azepam oral suspension, 204; enalapril oral Ephedra Ban: No Shortage of Reasons (FL), tic Category for Healthcare Professionals suspension, 254; lansoprazole oral suspen- 195 (A), 106 sion, 58; sodium bicarbonate oral solution, Epinastine, effective for ocular allergies (TT), Heart disease, education among consumers 204; spironolactone oral suspension, 139; 234 lacking (WN), 238 ursodiol oral suspension, 139 ePocrates, mobile reference suite available Heart failure, §-blocker use in African Ameri- Continuing Professional Development in (WN), 296 cans (A), 336; diuretics harmful (TT), 186; Pharmacy (FL), 303 Epoetin alfa, compared with darbopoetin mortality risk factors identified (TT), 343; Corsberg, Christine (coauthor) see Motl, Su- (TT), 45 outcomes with candesartan (TT), 185; out- sannah E (A), 106 Erythropoietin for Prevention and Treatment comes with carvedilol (TT), 42; outcomes Corticosteroids, inhaled, do not slow fetal of Anemia in the Intensive Care Unit (A), with nesiritide (TT), 42 growth (TT), 184; safety in breast-feeding 283 Hepatitis B, Web site launched (WN), 48 (A), 92 Escitalopram, in pediatric depression (TT), Hepatitis C, early treatment with peginterfer- Cost, US generic drugs cost less than Canadi- 292 on alfa (TT), 44; successful treatment with an drugs (FL), 349 Estrogen replacement therapy, poses low risk peginterferon alfa-2a and ribavirin (TT), Counterfeit medications, tips on avoidance for recurrent endometrial cancer (TT), 125; 187; vaccine possible (WN), 128; Web-based (PF), 246 study halted prematurely (TT), 190 patient support (WN), 48 Crouch, Michael A (coauthor) see Veverka, Etanercept, rapidly improves psoriasis (TT), Hilaire, Michelle L (author) Training Pharma- Angie, 336 43 cy Technicians in Community Pharmacy Exemestane, reduces breast cancer recurrence About Technical Aspects of Blood Glucose Cucchia, Gianni (coauthor) see Zullino, Daniele F, 334 (WN), 194 Meters (A), 178 Cyclobenzaprine, splitting tablets provides Exendin-4, improves glucose and weight con- Hirata, Sumio (author) Various Dosing wrong dose (WN), 347 trol (TT), 44 Weights and Correction to Serum Digoxin FDA Adverse Event Reports on Use of Sibu- Assays in Hemodialysis Patients (A), 221 tramine: An Exploratory Analysis (A), 323 Hispanics, attitudes differ about health de- D-F FIRST Consult, wireless support tool pending upon country of birth (WN), 297 launched (WN), 193 HIV-1 immunogen, restores T cell activity Fluorouracil, interaction with warfarin (A), 77 (WN), 345 Dalteparin, approved for deep-vein thrombo- Fluoxetine, safe during lactation (WN), 49 Hosta-Mateu, Victor (coauthor) see Poquet- sis (WN), 193 Fluticasone, cream available (WN), 238 Jornet, Jaime E (A), 71 Darbepoetin alfa, outcomes similar to epoetin Fluvastatin, reduces coronary heart disease Hypertension, aggressive management needed alfa (TT), 45 following kidney transplantation (TT), 46 (TT), 42; association with citalopram (A), 14; Deal, Eli N (author) Erythropoietin for Pre- Fosamprenavir/ritonavir, versus lopinavir / ri- induced by rofecoxib in older adults (A), 80 vention and Treatment of Anemia in the In- tonavir (TT), 290; versus nelfinavir (TT), 290 Hypertension Associated with Citalopram tensive Care Unit (A), 283 Freeny, Ingrid C (coauthor) see Nice, Frank J (A), 14 Decongestants, safety in breast-feeding (A), (A), 17, 85, 165 21 From the Literature, 51, 132, 195, 243, 303, 349 DeEugenio, Deborah (coauthor) see Nice, From the States, 55, 137, 199, 248, 308, 353 I-L FranJ (kA) , 17, 85, 165 Fujita, Minori (coauthor) see Hirata, Sumio Defining “Pharmacy Technician” (A), 96 (A), 221 Illinois, technician training statutes (FS) Depression, use of escitalopram in pediatrics Furukubo, Taku (coauthor) see Hirata, Sumio Imatinib, association with panic attacks (A), 11 (TT), 292 (A), 221 Improved Stability of Treprostinil Sodium Diabetes, antibiotic treatment for foot infec- with Proper Vial Puncture Technique and tions (TT), 120; management program re- Adapter Use (A), 270 duces costs, improves quality (WN), 298 G-H Infant formula, information available (WN), Digoxin, correction for hemodialysis (A), 221 242 DiMino, Traci A (coauthor) see Nice, Frank J Garvin, Cory G (coauthor) see Deal, Eli N Infliximab, long-term safety shown (TT), 343; (A), 17, 85, 165 (A), 283 maintains fistula closures in Crohn's dis- Diuretics, harmful in heart failure (TT), 186; Gastrointestinal drugs, safety in breast-feed- ease (TT), 187 safety in breast-feeding (A), 91 ing (A), 93 Influenza, program to increase pediatric vac- Diverticular disease, brief review (MP), 372 Gaynor, Ellen R (coauthor) see Tanvetyanon, cination rates (WN), 301; vaccination rates Docetaxel, increases breast cancer survival Tawee (A), 226 low among healthcare workers (WN), 300 (TT), 45 Generics, promoted to save money (WN), 298 Internet pharmacies, depleting Canada’s Doering, Paul L (coauthor) see Boothby, Lisa Gilad, Ronit (coauthor) see Lamp, Yair (A), drug supply (PF), 197 A (A), 215 151 Ipratropium bromide, association with para- Duloxetine, effective for stress urinary incon- Giunta, Giovanni (author) Subdural Hema- lytic ileus (A), 71 tinence (TT), 294 toma Due to Probable Warfarin—-Fluorouracil Iqbal, Mohammad Masud (author) Thera- Dutasteride, faster onset than finasteride (TT), Interaction (A), 77 peutic Options in the Treatment of Cloza- 237 Glaucoma, brief review (MP), 320 pine-Induced Adverse Effects (A), 155 Effectiveness of an Amiodarone Protocol GlaxoSmithKline, launches Web site for Izumi, Satoshi (coauthor) see Hirata, Sumio and Management Clinic in Improving Ad- those with hepatitis B (WN), 48 (A), 221 herence to Amiodarone Monitoring Graham, Maqual R (author) Effectiveness of Jaco, Vi T (coauthor) see Boothby, Lisa A (A), Guidelines (A), 5 an Amiodarone Protocol and Management 215 374 J PHarmTecHNot @ Vowme2 0 @ Novemser/Decems2e0r04 INDEX journal of Pharmacy Technology, author and Other Healthcare Professionals Part I Approval, 364; Essential Math and Calculations guidelines, ifc-J/F, ife-M/A, ifc-M/J, ifc- (A), 17 for Pharmacy Technicians, 311; Handbook of J/A, ife-S/O, ifc-N/D; subscription order Medications and Breast-Feeding: A Guide Nonprescription Drugs: An Interactive Approach form, 40, 119, 183, 233, 287, 341 for Pharmacists, Pharmacy Technicians, te Self-Care, 14th edition, 358; Herbal-Drug In- Jungnickel, Paul W (author) book review, 140 and Other Healthcare Professionals Part II teractions and Adverse Effects: An Evidence- Katz, Michael J (author) Alzheimer’s Disease (A), 85 Based Quick Reference Guide, 359; Marketing for (MP), 212; Diverticular Disease of the In- Medications and Breast-Feeding: A Guide Pharmacists, 59; Supervision: A Pharmacy Per- testines (MP), 372; Glaucoma (MP), 320; for Pharmacists, Pharmacy Technicians, spective, 59; Mosby's Complementary & Alterna- Polycystic Ovary Syndrome, (MP) 264; and Other Healthcare Professionals Part tive Medicine: A Research-Based Approach, 2nd Smallpox (MP), 148; Systemic Lupus Ery- III (A), 165 edition, 360; Pagliaro’s Comprehensive Guide to thematosus (MP), 68 Megna, James L (coauthor) see Iqbal, Mo- Drugs and Substances of Abuse, 359; Pharmacy Kitz, Michael J (coauthor) see Hilaire, hammad Masud (A), 155 Technician Certification Exam Review: 2nd Edi- Michelle L (A), 178 Menopausal Hormone Therapy (FL), 51 tion, 256; Teddy Bear Book: Pediatric Injectable Kreling, David H (author) book review, 59 Mercaptopurine, generic approved (WN), 194 Drugs, 7th edition, 361 Kumpf, Vanessa J (author) book review, 311 Mesalazine, reduces risk of colorectal cancer Nice, Frank J (author) Medications and Laminar flow hoods, positive pressure critical (TT), 46 Breast-Feeding: A Guide for Pharmacists, for sterile preparations (WN), 191 Metered-dose inhalers, keeping track of dos- Pharmacy Technicians, and Other Health- Lamivudine/zidovudine, copackaged with es (WN), 47 care Professionals Part I (A), 17; (author) nevirapine (WN), 299 Metformin, liquid available (WN), 127 Medications and Breast-Feeding: A Guide Lampl, Yair (author) Topiramate Effective in Methadone, deaths not linked to treatment for Pharmacists, Technicians, and the Treatment of Intractable Glossodynia centers (WN), 130 Other Healthcare Professionals Part II (A), (A), 151 Methamphetamine, withdrawal associated 85; (author) Medications and Breast-Feed- Lansoprazole, oral suspension (CF), 58 with mental changes (TT), 125 ing: A Guide for Pharmacists, Pharmacy Levetiracetam, beneficial in Parkinson's dis- Methotrexate, Web site available (WN), 301 Technicians, and Other Healthcare Profes- ease (TT), 236; for persistent seizures (TT), Michigan, national technician certification sionals Part Ill (A), 165 45 (FS), 200; possibility of technician registra- The North Dakota Telepharmacy Project: Lidocaine, for osteoarthritis (TT), 235 tion (FS), 137; technician education (FS), 56; Restoring and Retaining Pharmacy Ser- Linezolid, effective for diabetic foot infections technician niche of practice (FS), 55; techni- vices in Rural Communities (A), 28 (TT), 120 cian wages (FS), 249 NovoLog 70/30, in type 2 diabetes (TT), 44 Lipid-lowering agents, safety in breast-feed- Migraines, in association with menses (TT), NovoLog Flex Pen, preferred by patients ing (A), 92 288 (WN), 345 Lipid therapy, compliance improves if drugs Miller, Stephen P (coauthor) see Phares, Ken- initiated in hospital (TT), 41 neth R (A), 270 O-R Lloyd, StanleyJ (author) Natural Family Mirtazapine, possible interaction with ven- Planning; A Safer Alternative (E), 3; (au- lafaxine (A), 334 thor) “Vibrant, Valuable, Visionary”: 2004 Misis-Del-Campo, Maite (coauthor) see Po- Octreotide for Refractory Diarrhea Associat- Pharmacy Technician Educators Council quet-Jornet, Jaime E (A), 71 ed with Capecitabine (A), 226 Annual Meeting Report (A), 267 Mississippi, technician training and skills Off-label prescribing, disapproved by public Lopinavir/ritonavir, once daily treatment pos- (FS), 251 (WN), 300 sibility (TT), 122; versus fosamprenavi/rr i- Motl, Susannah E (author) Health Informa- Ofloxacin, otic solution for ear infections tonavir (TT), 290 tion Web Sites by Therapeutic Category for (WN), 240 Lyme disease, prevention product launched Healthcare Professionals (A), 106 Ohtani, Hisakazu (coauthor) see Hirata, (WN), 239 Moxifloxacin, efficacy in chronic bronchitis Sumio (A), 221 (TT), 188 Olanzapine, delays schizophrenia relapse Mycophenolate mofetil, efficacy in lupus (TT), 124 M-N nephritis (TT), 188 O’Mara, Neeta Bahal (author) book review, Mydriasis, Hypertension, and Tachycardia 362 Possibly Associated with Venlafaxine Omega-3 fatty acid, in epilepsy (WN), 241 Malhotra, Pankaj (author) Panic Attack Asso- Augmentation of Mirtazapine (A), 334 Omeprazole, compliance with OTC products ciated with Imatinib Mesylate? (A), 11 Myocardial infarction, outcomes with valsar- (WN), 126 Manley, Harold J (coauthor) see Deal, Eli N tan (TT), 41 Ophthalmics, safety in breast-feeding (A), 94 (A), 283; see Graham, Maqual R (A), 5 Narcotics, safety in breast-feeding (A), 24 Oral contraceptives, associated with cardio- Marijuana, abuse increased among adults National Association of Boards of Pharmacy vascular risks (TT), 293 (WN), 239 (NABP), acts on illegal prescription impor- Osmany, Saabry (coauthor) see Iqbal, Mo- Marken, Patricia A (coauthor) see Deal, Eli N tation (PF), 307 hammad Masud (A), 155 (A), 283 Natural Family Planning: A Safer Alterna- Osteoporosis, drugs associated with in- Measles-mumps-rubella vaccine, no link tive (E), 3 creased visits and treatment (WN), 295; with autism (FL), 349 Nelfinavir, versus fosamprenavir /r itonavir guidelines for prevention (WN), 192; risks Medical Anti-Terrorism Countermeasures (TT), 290 identified by pharmacists (WN), 194; treat- (FL), 132 Nesiritide, improves heart failure outcomes ment with teriparatide (TT), 291; under- Medical Problems: Brief Reviews, 68, 148, (TT), 42 treated (WN), 48 212, 264, 320, 372 Nevirapine, copackaged with lamivudine /zi- Ota, Miyuki (coauthor) see Hirata, Sumio Medicare Drug Act, enhanced role for phar- dovudine (WN), 299 (A), 221 macists (PF), 52 New Publications, Allen's Compounded Formu- Overstreet, Karen M (author) book review, Medication errors, campaign focuses on re- lations: The Complete US Pharmacist Collection, 312 ducing inappropriate home use (WN), 300; 255; Application and Review of Pediatric Phar- Paclitaxel, drug-eluting stent comparable to reduced with bar coding (PF), 53; USP re- macotherapy, 362; Bacterifao rB reakfast: Probi- sirolimus-eluting stent (TT), 184 port (PF), 53 oticfso rG ood Health, 311; Breast Health and Pain, neuropathic pain affects quality of life Medication nonadherence, increases when Common Breast Problems: A Practical Approach, (WN), 238; new guidelines for treating neu- copays increase (PF), 52 312; Does God Need Our Help? Cloning, Assist- ropathic pain (WN), 49 Medication safety, improved by ed Suicide, and Other Challenges in Bioethics, Pan, Wei (coauthor) see Phares, Kenneth R pharmacy / nursing partnership (PF), 52 140; Dosage Calculations, 7th edition, 140; Dia- (A), 270 Medications and Breast-Feeding: A Guide betes Management Services: A Pharmacist’s Re- Pancreatic cancer, associated with chronic as- for Pharmacists, Pharmacy Technicians, source Guide, 363; Drugs: From Discovery to pirin (TT), 123 WWW. JPHARMTECHNOL.COM Novemser/Decemser 2004 m Voitume 20 @ J PHARMTECHNOL 375 Panic Attack Associated with Imatinib Me- Psoriasis, improvements with etanercept (TT), Smoking, associated with breast cancer (TT), sylate? (A), 11 43 123; cessation with rimonabant (TT), 189 Panic attacks, association with imatinib (A), Psychotherapeutic drugs, safety in breast- Sodhi, Punita K (author) Appearance of Reti- 11 feeding (A), 172 nal Hemorrhages in Patients on Daily-Dose Paralytic Ileus Possibly Associated with Putnam, Janice (author) book review, 358 Anti-Tubercular Therapy (A), 276 Nebulized Ipratropium Bromide (A), 71 Quetiapine, achieves remission of mania in Sodium bicarbonate, oral solution (CF), 204 Park, Jeong M (author) book review, 359 bipolar disorder (TT), 237; effective in elder- Sodium sulfacetamide, new formulations PDA, medical dictionary available (WN), 241; ly (TT), 293 available (WN), 238 patient leaflets available (WN), 240; stan- Radiopharmaceuticals, safety in breast-feed- Somatropin, reduces visceral adipose tissue ing (A), 174 dard-of-care guidelines available (WN), 240 (TT), 187; role in HIV (TT), 122 Peanuts, educational book available for aller- Rahman, Atig (coauthor) see Iqbal, Moham- Spironolactone, oral suspension (CF), 139 gies (WN), 295; reduce risk of gallstones mad Masud (A), 155 Statins, beneficial in acute coronary syndrome (WN), 298 Ratan, Simmi K (coauthor) see Sodhi, Punita (TT), 186 Peginterferon alfa, early treatment in hepati- K (A), 276 Stavchansky, Marcus M (author), FDA Ad- tis C (TT), 44 Retinal hemorrhages, associated with anti-tu- verse Event Reports on Use of Sibutramine: Peterson, Charles D (author) The North bercular therapy (A), 276 An Exploratory Analysis (A), 323 Dakota Telepharmacy Project: Restoring Ribavirin, with peginterferon alfa-2a effective Stroke, not prevented with B vitamins (TT), and Retaining Pharmacy Services in Rural in hepatitis (TT), 187 122; patients not treated according to guide- Communities (A), 28 Rimonabant, effective in smoking cessation lines (TT), 291; treatment with recombinant Phares, Kenneth R (author) Improved Stabili- and weight control (TT), 189 factor Vila (WN), 297 ty of Treprostinil Sodium with Proper Vial Risperidone, long-acting form in young Subdural Hematoma Due to Probable War- Puncture Technique and Adapter Use (A), adults (TT), 125 farin—-Fluorouracil Interaction (A), 77 270 Robinson, Melanie (coauthor) see Motl, Su- Systemic lupus erythematosus, brief review PharmaCE, order form, 62, 143, 206, 258, 314, sannah E (A), 106 (MP), 68 366; questions, 63, 144, 207, 259, 315, 367 Rofecoxib, associated with hypertension (A), Tacrolimus, compared with pimecrolimus (TT), Pharmacist, adversely affected by prescriber 80 120; effective with clocortolone (TT), 43 intimidation (PF), 197; applications avail- Rojas-Fernandez, Carlos H (coauthor) see Tagoff, Shari S (coauthor) see Segarra-Newn- able for Pharmacist Medication-Use Safety Eng, Marty L (A), 80 ham, Marisel (A), 229 Award (PF), 245; role in cholesterol control Rosacea, linked to bacteria (TT), 235 Tamsulosin, more efficacious than phytother- (PF), 135; role in Medicare Drug Act (PF), Rosuvastatin, effective in metabolic syndrome apy for benign prostatic hypertrophy (TT), 52; trust by public (PF), 135 (TT), 185 237 Pharmacy Compounding Accreditation Rouse, Michael J (author) Continuing Profes- Tanvetyanon, Tawee (author) Octreotide for Board (PCAB), established (PF), 247 sional Development in Pharmacy (FL), 303 Refractory Diarrhea Associated with Pharmacy Focus, 52, 135, 197, 245, 307, 351 Rovnack, Marissa B (coauthor) see Nice, Capecitabine (A), 226 Pharmacy/Nursing Partnership (PF), 52 Frank J (A), 17, 85, 165 Telepharmacy, role in communities (A), 28 Pharmacy students, more entering residencies Teriparatide, effective foi osteoporosis (TT), (PF), 246 291 S-Z Pharmacy Technician Certification Board Test Your Knowledge, answers, 65, 146, 210, (PTCB), to study practice of pharmacy tech- 262, 317, 369; questions, 2, 70, 150, 214, 266, nicians (PF), 246 Sachdev, Mahipal S (coauthor) see Sodhi, 322 technicians, charting a course for Punita K (A), 276 Testosterone gel, effective for erectile dys- the future (FS), 200; definition (A), 96; find- Sagduyu, Afgsin (author) Hypertension Asso- function and low libido (TT), 189 ing a niche (FS), 55; glucose meter training ciated with Citalopram (A), 14 Therapeutic Options in the Treatment of (A), 178; Illinois Pharmacy Practice Act (FS), Saquinavir, superior safety profile with boost- Clozapine-Induced Adverse Effects (A), 199; reevaluation of training (PS), 55; regula- ed regimen (TT), 121 155 tory definitions (TT), 99; training course Sawada, Yasufumi (coauthor) see Hirata, Therapeutic Trends, 41, 120, 184, 234, 288, 343 launched (PF), 198 Sumio (A), 221 Thyroid drugs, safety in breast-feeding (A), Phenytoin, interaction with clozapine (A), 280 Schizophrenia, benefits of risperidone in 22 Phillips, Keri (coauthor) see Motl, Susannah young adults (TT), 125; delayed relapse Timpe, Erin M (coauthor) see Motl, Susan- E (A), 106 with olanzapine (TT), 124; improvements nah E (A), 106 Pimecrolimus, compared with tacrolimus for with ziprasidone (TT), 124 Tinidazole, for amebiasis (WN), 128; for tri- eczema (TT), 120 Schwartz, Thomas L (coauthor) see Iqbal, chomoniasis (WN), 240 Plague, medical countermeasures (FL), 132 Mohammad Masud (A), 155 Topiramate Effective in the Treatment of In- Plan B, inappropriate for OTC (TT), 293 Sea-Band, approved by FDA (WN), 130 tractable Glossodynia (A), 151 Polycystic ovary syndrome, brief review Segarra-Newnham, Marisel (author) Valacy- Training Pharmacy Technicians in Commu- (MP), 264 clovir and Postherpetic Neuralgia (A), 229 nity Pharmacy About Technical Aspects of Poquet-Jornet, Jaime E (author) Paralytic Sentiirk, Vesile (coauthor) see Sagduyu, Blood Glucose Meters (A), 178 Ileus Possibly Associated with Nebulized Afsgin (A), 14 Trans fats, associated with heart disease Ipratropium Bromide (A), 71 Sepsis, guidelines (WN), 192 (WN), 127 Postherpetic neuralgia, treatment guideline Serostim, effective in decreasing visceral adi- Trastuzumab, ineffective for lung cancer (TT), available (WN), 347 pose tissue (TT), 187 123 Powers, Mary F (coauthor) see Hilaire, Shad, Mujeeb U (author) A Complex Interac- Treprostinil sodium, improved stability (A), Michelle L (A), 178 tion Between Clozapine and Phenytoin (A), 270 Pregnancy, noncompliance with asthma med- 280 Twitty, Michelle Gravlin (author) book re- ications (WN), 126 Sharps, disposal through the mail (WN), 241 view, 359 Prescriptions, made available OTC interna- Sherman, Justin J (author) book review, 363 Uenishi, Koji (coauthor) see Hirata, Sumio tionally (PF), 135 Shields, Kelly M (author) book review, 360 (A), 221 Prevalence of Smoking and Attitude Toward Sibutramine, analysis of FDA adverse event United States Pharmacopeia (USP), reports Smoking Cessation Among Community reports (A), 323 on medication errors (PF), 53 Pharmacists, Saudi Arabia, 329 Sildenafil, safe with a-blockers (TT), 236 Ursodiol, oral suspension (CF), 139 Prostate, information available on Internet Sirolimus, drug-eluting stent comparable to Vaccines, safety in breast-feeding (A), 169 (WN), 347 paclitaxel-eluting stent (TT), 184 Valacyclovir and Postherpetic Neuralgia (A), Protecting Consumers from Counterfeit Smallpox, brief review (MP), 148; medical 229 Drugs (FL), 243 countermeasures (FL), 132 Valsartan, improves outcomes post-MI (TT), 41 376 =} PHarmTecHNot @ Vowme 20 o Novemser/Decems2e0r04 WWW. JPHARMTECHNOL.COM Various Dosing Weights and Correction to Yamakawa, Tomoyuki (coauthor) see Hirata, Serum Digoxin Assays in Hemodialysis Sumio (A), 221 Index Abbreviations Patients (A), 221 Yasmin, Laila (coauthor) see Iqbal, Moham- Varma, Subhash C (coauthor) see Malhotra, mad Masud (A), 155 Pankaj (A), 11 Ziprasidone, improves cognitive function Article Vellenga, Ray (author) book review, 140, 311 (TT), 124 Velluti, Francesca (coauthor) see Giunta, Gio- Zullino, Daniele F (author) Mydriasis, Hy- Compounding Formulations vanni (A), 77 pertension, and Tachycardia Possibly Asso- Editorial Venlafaxine, possible interaction with mir- ciated with Venlafaxine Augmentation of From the Literature tazapine (A), 334 Mirtazapine (A), 334 Verma, Lalit K (coauthor) see Sodhi, Punita Frthoe Smtat es K (A), 276 Veverka, Angie (author) The Effects of B- Advertisers Insbiackd ceove r Adrenergic Blockers in African Americans Inside front cover Viawgirtah, Chharlfo naivca ilHaebalret tFharioluurgeh (IAn)t,e r3n3e6t may be ADOPT-A-TECH, 50, 95 Letter American Association of Techni- counterfeit (WN), 346 cians (AAPT), 61, 131, 177, 209, 244, 252, Medical Problems “Vibrant, Valuable, Visionary”: 2004 Phar- 275, ibe-S/O Pharmacy Focus macy Technician—Educators Council An- Christian Pharmacists Fellowship Interna- nual Meeting Report (A), 267 tional, 211 BSEATRTSheEr?apT euRticR T rends Vitamins, not protective against stroke (TT), Harvey Whitney Books Company, Certifica- 122; variable vitamin E absorption (WN), tion Review for P’ Technicians, Sixth 129 edition, ibe-M/A, 261, 342; Medical Abbrevia- Wade, Michael (coauthor) see Phares, Ken- tions, 11th edition, 67; Pediatric Drug Formu- neth R (A), 270 lations, Fifth Edition, ibc-J /F, ibc-M/J, 286, State t of oF hip, manageamnde monnthtly, ci r- Warfarin, interaction with fluorouracil (A), 77 378; Principles of Pharmacoeconomics, Third culation (6 issues, $159.00 annually) of the journal of Phar- Webster, Kathy D (author) book review, 255 edition, ibc-J/ A, 306, ibce-N/D macy Technology, publicationno . 8755-1225. Owner, Har- Weiser, William E (coauthor) see Phares, Pharmacy Technician Educators Council vey WhitBoonks eComypan y. Publisher, editor, and Kenneth R (A), 270 (PTEC), 105, 196, 202, 302 managing editor: Harvey AK Whitney Jr.H eadquarters What's New, 47, 126, 191, 238, 295, 345 14th Annual CAPT-Alberta Conference: of publisher, owner, and : 8044 Montgomery When Prescription Drugs Go Over-the- Viva La Technician!, 242 bRondoholPadeOr Bsdo, x ,m4269 o6, rCitanngdc otiahernO gHsn e4c5eua2r4it2ts.y ihK,on,lodew rns : Counter: Where Are the Boundaries? (A), none. Average no. of copies of each issue from October 215 2003 to October 2004 and no. of copies of November /De- Wilson, Debbie L (author) Defining “Phar- cember 2003 to September / October 2004 issue: A. total macy Technician” (A), 96 no. of copies printed (net press run) 633, 600; B. paid Wilson, James P (coauthor) see Stavchansky, and / or requested circulation (1) paid or requested mail Marcus M (A), 323 subsc40r7, 3i44;p C.t totial opaind asnd/ or circulation 477, 417; D. free distribution by mail 61, 61; F. Wright, Marcia A (coauthor) see Graham, Maqual R (A), 5 total free distributio6n1 , 61; G. total distribution 538, 478; H. copies not distributed 95, 122; I. Total 633, 600. No. of Ximelagatran, anticoagulation following knee issues published annually: 6. Dateo ff iling 1 October replacement (TT), 41 2004. Signed: Harvey AK Whitney Jr,p ublisher. Novemser/Decemser 2004 @ Voiume 20 @ J PHaRMTECHNOL 377